BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36216981)

  • 1. Quinoline-imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity.
    Diaconu D; Antoci V; Mangalagiu V; Amariucai-Mantu D; Mangalagiu II
    Sci Rep; 2022 Oct; 12(1):16988. PubMed ID: 36216981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
    Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
    J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzoquinoline Derivatives: An Attractive Approach to Newly Small Molecules with Anticancer Activity.
    Oniciuc L; Amăriucăi-Mantu D; Diaconu D; Mangalagiu V; Danac R; Antoci V; Mangalagiu II
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Dual Evaluation of Quinoline and Quinolinium Iodide Salt Derivatives as Potential Anticancer and Antibacterial Agents.
    Jin G; Xiao F; Li Z; Qi X; Zhao L; Sun X
    ChemMedChem; 2020 Apr; 15(7):600-609. PubMed ID: 32068948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Qualitative Structure Activity Relationship Evaluations of Quinoline-Based Bisarylimidazoles as Antibacterial Motifs.
    Al-Qawasmeh RA; Huthail BB; Sinnokrot MO; Semreen MH; Odeh RA; Abu-Zarga MH; Tarazi H; Yousef IA; Al-Tel TH
    Med Chem; 2016; 12(6):563-73. PubMed ID: 27188185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
    El-Gohary NS; Shaaban MI
    Eur J Med Chem; 2017 May; 131():255-262. PubMed ID: 28334654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
    Gibson MZ; Nguyen MA; Zingales SK
    Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro anticancer evaluation of newly designed and characterized tri/tetra-substituted imidazole congeners- maternal embryonic leucine zipper kinase inhibitors: Molecular docking and MD simulation approaches.
    Mahapatra M; Mohapatra P; Pakeeraiah K; Bandaru RK; Ahmad I; Mal S; Dandela R; Sahoo SK; Patel H; Paidesetty SK
    Int J Biol Macromol; 2023 Sep; 249():126084. PubMed ID: 37532192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
    Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
    Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis & Anticancer Evaluation of New Substituted 2-(3,4- Dimethoxyphenyl)benzazoles.
    Karaaslan C; Duydu Y; Ustundag A; Yalcin CO; Kaskatepe B; Goker H
    Med Chem; 2019; 15(3):287-297. PubMed ID: 29992893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel purine benzimidazoles as antimicrobial agents by regulating ROS generation and targeting clinically resistant Staphylococcus aureus DNA groove.
    Wang YN; Bheemanaboina RRY; Cai GX; Zhou CH
    Bioorg Med Chem Lett; 2018 May; 28(9):1621-1628. PubMed ID: 29598912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in-vitro anti-proliferative with antimicrobial activity of new coumarin containing heterocycles hybrids.
    Abdelaziz E; El-Deeb NM; Zayed MF; Hasanein AM; El Sayed IE; Elmongy EI; Kamoun EA
    Sci Rep; 2023 Dec; 13(1):22791. PubMed ID: 38123695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria.
    Dokla EME; Abutaleb NS; Milik SN; Kandil EAEA; Qassem OM; Elgammal Y; Nasr M; McPhillie MJ; Abouzid KAM; Seleem MN; Imming P; Adel M
    Eur J Med Chem; 2023 Feb; 247():115040. PubMed ID: 36584632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study.
    El-Khouly OA; Henen MA; El-Sayed MA; Shabaan MI; El-Messery SM
    Bioorg Med Chem; 2021 Feb; 31():115976. PubMed ID: 33388654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Heterocyclic choline analogues based on 1,2,3,4-tetrahydro(iso)quinoline scaffold with anticancer and anti-infective dual action.
    Zablotskaya A; Segal I; Geronikaki A; Shestakova I; Nikolajeva V; Makarenkova G
    Pharmacol Rep; 2017 Jun; 69(3):575-581. PubMed ID: 28364698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, regioselective synthesis and cytotoxic evaluation of 2-aminoimidazole-quinoline hybrids against cancer and primary endothelial cells.
    Singh K; Verma V; Yadav K; Sreekanth V; Kumar D; Bajaj A; Kumar V
    Eur J Med Chem; 2014 Nov; 87():150-8. PubMed ID: 25247771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.